Experienced in Essential Thrombocythemia

Dr. Nandini Ignatius

Hematology Oncology
HackenSack Meridian health
Titan Health Partners, LLC DBA Astera Cancer Care
1 Washington Boulevard, Suite 9, 
Robbinsville, NJ 
Offers Telehealth
Experienced in Essential Thrombocythemia
HackenSack Meridian health
Titan Health Partners, LLC DBA Astera Cancer Care
1 Washington Boulevard, Suite 9, 
Robbinsville, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nandini Ignatius is a Hematologist Oncology provider in Robbinsville, New Jersey. Dr. Ignatius is rated as an Experienced provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Deep Vein Thrombosis, and Drug-Induced Thrombocytopenia.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Bangalore Medical College, Bangalore University
Residency
John H Stroger Jr Hospital of Cook County
Specialties
Hematology Oncology
Licenses
Internal Medicine in NJ
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Illinois at Chicago Medical Center
Hospital Affiliations
Robert Wood Johnson University Hospital At Hamilton
Saint Peter's University Hospital
Robert Wood Johnson University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Titan Health Partners, LLC DBA Astera Cancer Care
1 Washington Boulevard, Suite 9, Robbinsville, NJ 8691.
Call: 732-314-0540
Other Locations
Titan Health Partners, LLC DBA Astera Cancer Care
9 Centre Drive, Suite 100, Monroe Township, NJ 8831.
Call: 609-395-5577

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3

1 Total Publications

Delayed response and survival from NovoTTF-100A in recurrent GBM.
Delayed response and survival from NovoTTF-100A in recurrent GBM.
Journal: Medical oncology (Northwood, London, England)
Published: November 06, 2012
Similar Doctors
Elite in Essential Thrombocythemia
Dr. John O. Mascarenhas
Hematology Oncology | Hematology
Elite in Essential Thrombocythemia
Dr. John O. Mascarenhas
Hematology Oncology | Hematology

Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (53.0 miles away)
212-731-7650
Languages Spoken:
English
See accepted insurances

John Mascarenhas is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Mascarenhas is rated as an Elite provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Aspiration, and Splenectomy.

Distinguished in Essential Thrombocythemia
Dr. Ross L. Levine
Hematology Oncology | Hematology | Oncology
Distinguished in Essential Thrombocythemia
Dr. Ross L. Levine
Hematology Oncology | Hematology | Oncology

Memorial Hematology Lymphoma Group

1275 York Ave, 
New York, NY 
 (51.5 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances

Ross Levine is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Levine is rated as an Elite provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Distinguished in Essential Thrombocythemia
Dr. Bruce G. Raphael
Hematology Oncology | Hematology | Oncology
Distinguished in Essential Thrombocythemia
Dr. Bruce G. Raphael
Hematology Oncology | Hematology | Oncology

New York University

240 E 38th St, 
New York, NY 
 (50.0 miles away)
212-263-7300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bruce Raphael is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Raphael is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration.

VIEW MORE ESSENTIAL THROMBOCYTHEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ignatius's expertise for a condition
ConditionClose
        • Experienced
        • Acute Mountain Sickness
          Dr. Ignatius is
          Experienced
          . Learn about Acute Mountain Sickness.
          See more Acute Mountain Sickness experts
        • Acute Myeloblastic Leukemia with Maturation
          Dr. Ignatius is
          Experienced
          . Learn about Acute Myeloblastic Leukemia with Maturation.
          See more Acute Myeloblastic Leukemia with Maturation experts
        • Acute Myeloblastic Leukemia without Maturation
          Dr. Ignatius is
          Experienced
          . Learn about Acute Myeloblastic Leukemia without Maturation.
          See more Acute Myeloblastic Leukemia without Maturation experts
        • Acute Myeloid Leukemia (AML)
          Dr. Ignatius is
          Experienced
          . Learn about Acute Myeloid Leukemia (AML).
          See more Acute Myeloid Leukemia (AML) experts
        • Agranulocytosis
          Dr. Ignatius is
          Experienced
          . Learn about Agranulocytosis.
          See more Agranulocytosis experts
        • ALK-Positive Non-Small Cell Lung Cancer
          Dr. Ignatius is
          Experienced
          . Learn about ALK-Positive Non-Small Cell Lung Cancer.
          See more ALK-Positive Non-Small Cell Lung Cancer experts
        View All 57 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Patient Details

          This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.